Classical Swine Fever live vaccine approved in China

Boehringer Ingelheim ’s China-developed Classical Swine Fever live vaccine approvedBoehringer Ingelheim received a marketing authorization for Ingelvac ® CSF MLV, the first classical Swine Fever live vaccine jointly developed by a multinational company and Chinese research institutesThe company reaffirms its commitment to supplying innovative swine vaccines for the Chinese industry
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news